Clinical Trial

Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
To explore the efficacy of Houyanqing Oral Liquid combined with conventional treatment in preventing and treating radiation-induced oral mucositis, so as to improve the quality of life of nasopharyngeal carcinoma patients received radiotherapy.
Protocol Amendment History 1 change
notable Enrollment increased: 244 -> 386 participants 2026-05-08
Trial Details
NCT Number NCT07311772
Lead Sponsor Sun Yat-sen University
Collaborators: Fujian Cancer Hospital, Eye & ENT Hospital of Fudan University, Zhejiang Cancer Hospital, West China Hospital, Yunnan Cancer Hospital, First Affiliated Hospital of Kunming Medical University, The First People's Hospital of Changzhou, Xiangya Hospital of Central South University, Affiliated Cancer Hospital of Shantou University Medical College, Wuzhou Red Cross Hospital, Hunan Cancer Hospital, Cancer Hospital of Guangxi Medical University, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Sun Yat-Sen University Cancer Center, Cancer Hospital Chinese Academy of Medical Science, Fifth Affiliated Hospital, Sun Yat-Sen University
Conditions Nasopharyngeal Cancinoma (NPC), Radiation-induced Oral Mucositis
Enrollment 386 participants
Start Date 2025-12-16
Primary Completion 2027-03-15 (estimated)
Study Completion 2027-08-15 (estimated)
Updated on ClinicalTrials.gov 2026-05-07